SWTX
SpringWorks Therapeutics Inc
Price:  
46.99 
USD
Volume:  
4,975,661.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SWTX EV/EBITDA

-241.0%
Upside

As of 2025-07-04, the EV/EBITDA ratio of SpringWorks Therapeutics Inc (SWTX) is -13.32. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. SWTX's latest enterprise value is 3,475.51 mil USD. SWTX's TTM EBITDA according to its financial statements is -260.90 mil USD. Dividing these 2 quantities gives us the above SWTX EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 11.9x - 13.8x 13.2x
Forward P/E multiples 18.9x - 34.2x 25.6x
Fair Price (64.48) - (46.88) (66.27)
Upside -237.2% - -199.8% -241.0%
46.99 USD
Stock Price
(66.27) USD
Fair Price

SWTX EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-06-30 -13.32
2025-06-27 -13.32
2025-06-26 -13.32
2025-06-25 -13.32
2025-06-24 -13.31
2025-06-23 -13.32
2025-06-20 -13.31
2025-06-18 -13.26
2025-06-17 -13.28
2025-06-16 -13.29
2025-06-13 -13.26
2025-06-12 -13.26
2025-06-11 -13.25
2025-06-10 -13.25
2025-06-09 -13.25
2025-06-06 -13.27
2025-06-05 -13.27
2025-06-04 -13.24
2025-06-03 -13.25
2025-06-02 -13.23
2025-05-30 -13.24
2025-05-29 -13.23
2025-05-28 -13.23
2025-05-27 -13.17
2025-05-23 -13.17
2025-05-22 -13.11
2025-05-21 -13.10
2025-05-20 -13.13
2025-05-19 -13.11
2025-05-16 -13.07
2025-05-15 -13.06
2025-05-14 -13.10
2025-05-13 -13.10
2025-05-12 -13.07
2025-05-09 -13.11
2025-05-08 -13.09
2025-05-07 -13.09
2025-05-06 -13.08
2025-05-05 -13.10
2025-05-02 -13.10
2025-05-01 -13.10
2025-04-30 -13.12
2025-04-29 -13.10
2025-04-28 -13.09
2025-04-25 -12.67
2025-04-24 -12.73
2025-04-23 -11.65
2025-04-22 -11.45
2025-04-21 -10.45
2025-04-17 -10.70